The article reports on the approval by the Food and Drug Administration (FDA) on a novel genetic test for breast cancer patients in the U.S. The test will determine whether a breast cancer patient has a potential for treatment with the drug Herceptin. The approved test is called the SPOT-...
Q: How do you decide whether someone is a good candidate for genetic testing? A: Say a patient came in to see me and her mother hadbreast cancerat the age of 38 and her mother's two sisters as well, and the grandmother had breast cancer, too. That would be a sign that that famil...
Women at risk for a genetic breast cancer disorder must understand what the genetic testing process involves. First, an expert reviews the family medical history to evaluate what sort of pattern of genetic breast cancer may be occurring. Next, the family member'stumorsample, if available, undergo...
Cynthia Graber
DNA research identifies 10 types of breast cancer, each of which could be treated differently. By Steve ConnorCancer is the quintessential genetic disease, so it comes as little surprise to find it has benefited most from the unravelling of the human genome - the blueprint of life written in...
Published during National Breast Cancer Awareness Month, the study lends new insights into how women cope with the results of BRCA testing for hereditary breast cancer—an increasingly used genetic test in which an "inconclusive" result is common. ...
Dr. Susan Trociolla, a 47-year-old cardiothoracic surgeon, tested negative for the BRCA mutation. But she found out she has an increased risk for other kinds of cancer, including some for which there is little preventative action. “I didn't want a genetic test that I could do nothing ...
This week, the FDA authorized a 23andMe test as the first at-home test for genetic breast cancer risk. Here's what to know before you try it.
Shares of genetic test maker Myriad Genetics rose as much as 4 percent on Tuesday, after actress Angelina Jolie detailed her decision to undergo radical double-mastectomy, following testing which showed she carried a gene for breast cancer.
Perceived risk of breast cancer, or genetic mutations associated with it may also predict decisions related to testing forBRCA1/2. Prior work has found women who perceive themselves to be at greater risk of developing the disease to be more likely to test forBRCA1/2, and at a higher price...